13F filing recap · Q3 2007
What did Bill & Melinda Gates Foundation Trust buy in Q3 2007?
Reported stock-position changes between this filing and the previous one.
Stock value
$9.12B
Positions
56
Estimated turnover
33.8%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
New positions
TYCTyco International Ltd$53.16Mreported value+1.20M sharesCOVCovidien Ltd$49.76Mreported value+1.20M sharesTELTe Connectivity Plc$42.48Mreported value+1.20M sharesAIGAmerican International Group, Inc.$33.83Mreported value+500.0K sharesTEVATeva Pharmaceutical Industries Limited$12.35Mreported value+277.6K sharesQDHCQuadramed Corp$5.75Mreported value+2.00M sharesRDNTRadnet, Inc.$5.52Mreported value+629.8K sharesEICUVisicu Inc$4.65Mreported value+613.0K sharesPMDUSDPsychemedics Corp$3.86Mreported value+222.7K sharesISREURPerspective Therapeutics, Inc.$3.55Mreported value+1.00M shares